News

Evidence increasingly suggests that infections play a critical role in triggering or exacerbating many chronic ...
Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...
Several other vaccines — for influenza ... A connection between a virus and neurological disease isn’t unheard of. Epstein-Barr virus, another herpesvirus that causes mono, has been linked to later ...
Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a ...
Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...
One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...
Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
The risk of MS is significantly higher in people with a specific gene variant called HLA-E*01:01 and a history of mono, a ...
A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...
Scientists at the University at Buffalo are working on a potential new vaccine to combat bird flu. They say it may be easier ...